Search the Newsreel

REXEL : Q2 sales & H1 2026 results

Rexel Développement SAS Q2 sales & H1 2026 Results Sales growth acceleration in Q2 across geographies Adj. Ebita margin up c. 40bps, reaching 6.2% in H1 26 2026 guidance raised Highlights: H1 26 sales reached €9,989m, with same-day sales growth of +5.1%, continuing to …

Exelixis Inc (EXEL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article from TradingKey provides an overview of Exelixis Inc (EXEL)'s dividend and stock split history. It notes that over the past five years, a total of $0.00 USD has been distributed in dividends, indicating no dividend payments have been made during this period. …

Exelon Gears Up to Report Q2 Earnings: Here's What You Need to Know

Exelon Corporation EXC is scheduled to release second-quarter 2026 results on July 30, before market open. The company delivered an earnings surprise of 2.25% in the last reported quarter. Let's discuss the factors that are likely to be reflected in the upcoming quarterly results. …

Exelon stock holds on earnings and dividend support

Exelon Corp. (US30161N1019) maintains its appeal to investors as a regulated utility, supported by its earnings, dividend, and capital investment. The company reported full-year revenue of $37.6 billion and net income of $1.8 billion in 2025, with adjusted operating earnings of $2.39 per share, …

Exelixis, Inc. Revenue Breakdown – BX:EX9

The article provides a revenue breakdown for Exelixis, Inc. (BX:EX9), highlighting that the company generated 1.84 billion CHF in its last fiscal year from its top segment, "Medicines for Difficult-to-treat Cancers." The United States was the greatest contributor to this revenue, accounting for 1.70 …

Exelixis Inc (EXEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Exelixis Inc (EXEL), categorizing it by business segments and geographical regions. CABOMETYX is highlighted as the dominant revenue source, contributing over 91% of the total, followed by license revenues. The United States accounts for the vast …

Exelixis Inc (EXEL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides an overview of Exelixis Inc (EXEL) shareholder structure, detailing major institutional holdings and shareholder types. It lists top shareholders like BlackRock and Farallon Capital, their proportion of shares, and changes in their holdings over time. The document also includes a historical …

Exelon stock trades steadily as regulated earnings and clean energy investments shape outlook

Exelon stock is driven by the stable cash flows of its regulated utility business and its focus on clean energy investments. Investors closely monitor earnings trends, capital spending, dividend capacity, and regulatory decisions that influence the company's financial performance and future growth. Exelon's balance …

EXEL|Exelixis Inc|Price:55.370|Chg%:-0.280

Exelixis Inc (EXEL) is an oncology company with strong fundamentals and high growth potential, though its stock performance has been average over the past month. The company's valuation is considered fair, and it has a high institutional ownership. Analysts generally rate EXEL as a …

Exelon Corp (EXC) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Exelon Corp (EXC), highlighting its current risk score and ranking within the Electric Utilities & IPPs industry. It details various risk metrics such as beta, VaR, maximum drawdown, and volatility, indicating the stock's performance characteristics relative to …

Exelon Corp (EXC) Valuation: PE, PB & Fair Value Analysis

This article analyzes Exelon Corp's (EXC) valuation metrics, noting a current valuation score of 6.16, placing it 54th out of 63 in its industry. The company's P/E ratio is 17.38, which is below its recent high and above its recent low. Key valuation ratios …

Exelon stock trades steady as regulated earnings and nuclear fleet underpin cash flows

Exelon (ISIN US30161N1019) is a leading regulated electric and gas utility holding company in the United States, whose stock performance is bolstered by stable earnings from its regulated distribution businesses and robust cash flow generation from its large nuclear fleet. The company's financial strength …

Exelon Corp. (EXC) Earnings Dates, Call Summary & Reports

This article provides detailed earnings information for Exelon Corp. (EXC), including upcoming earnings dates, historical performance, and analyst consensus. Exelon is scheduled to report its Q2 2026 earnings before market open on July 30, 2026, with a consensus EPS forecast of 7.73. The article …

Exelon Corp (EXC) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Exelon Corp (EXC), outlining major institutional holders like BlackRock, State Street, and Vanguard, and their respective proportions. It also presents a breakdown of shareholder types, including investment advisors, pension funds, and hedge funds. Furthermore, the article provides …

Exelon (EXC) Time Of Day Pricing Launch Puts Valuation Back In Focus

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Exelon (EXC) is drawing fresh attention after its Illinois utility, ComEd, launched a Time-of-Day Pricing program and as investors look ahead to the company's …

EXC|Exelon Corp|Price:47.348|Chg%:+0.068

Exelon Corp (EXC) shows stable fundamentals and high growth potential, with its valuation considered fairly valued within the Electric Utilities & IPPs industry. Institutional ownership is high, and analysts largely rate it as "Hold" with a target price of $49.24. The company exhibits strong …

EXEL Maintained by Morgan Stanley -- Price Target Raised to $53

Morgan Stanley has maintained an Equal-Weight rating on Exelixis (EXEL) while raising its price target from $50.00 to $53.00, an increase of 6%. Despite this cautious optimism, GuruFocus assesses EXEL as 29.1% overvalued with a GF Value™ of $42.86 against its current price of …

EXC|Exelon Corp|Price:47.280|

Exelon Corp's fundamentals are stable with high growth potential, and its valuation is considered fair within the Electric Utilities & IPPs industry. The stock has high institutional ownership and analysts generally rate it as a "Hold" with a target price of $49.24. Despite average …

Exelon Corp. stock outperforms competitors on strong trading day

Exelon Corp. (EXC) stock rallied 1.24% to $47.28 on Thursday, outperforming the broader market which saw the S&P 500 Index and Dow Jones Industrial Average decline. This marked the second consecutive day of gains for Exelon, occurring during an overall poor trading session for …

Exelon Corp (EXC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Exelon Corp (EXC), focusing on its current price momentum, support and resistance levels, and various technical indicators. The stock currently has a price momentum score of 2.32 and is trading between a resistance level of $48.71 and …

Exelon (EXC) to Release Quarterly Earnings on Thursday

Exelon (EXC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Exelixis to Release Second Quarter 2026 Financial Results on Wednesday, August 5, 2026

Exelixis, Inc. announced that it will release its second quarter 2026 financial results on Wednesday, August 5, 2026, after market close. The company will also host a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT to discuss these results and …

Exelon stock holds on to utility scale as earnings framework stays intact

Exelon (NASDAQ: EXC) stock maintains its utility-centric investment appeal, driven by a regulated earnings profile and stable cash flow. The company reported a $2.3 billion quarterly revenue and projected 2026 adjusted operating earnings of $2.64 to $2.74 per share, anchoring its valuation to rate-base …

Exelixis sets Aug. 5 webcast to discuss Q2 results and update

Exelon (EXC) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Exelon (EXC), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. The Zacks …

Exelon stock trades near recent highs as regulated earnings support growth

Exelon Corp. (ISIN US30161N1019) stock is trading near recent highs, supported by consistent regulated utility earnings and cash flow. The company maintains a strong dividend policy, backed by increasing revenue and EPS from its regulated transmission and distribution businesses. Exelon also plans significant capital …

Exelon Corp. (PEO) Q4 2023 Earnings Report - Results, Call & Slides

Exelon (PEO) reported its Q4 2023 earnings, beating both EPS and revenue expectations. The company posted an actual EPS of €0.53 against a consensus of €0.51 and actual revenue of €4.70 billion compared to an expected €3.39 billion, representing a 15.02% year-over-year growth. The …

Exelon Rate Base Is Growing 8% a Year. So, Why Is Its Free Cash Flow Still Negative?

Exelixis (EXEL) Earnings Expected to Grow: Should You Buy?

Exelixis (EXEL) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to …

Exelon stock trades steadily as regulated utility earnings and clean energy investments shape outlook

Exelon (EXC) stock is influenced by its stable regulated electric and gas utility earnings, dividend profile, and extensive investments in grid modernization and clean energy. The company reported roughly $21.2 billion in revenue for 2023 and emphasized its multi-year capital expenditure plan, aiming to …

Exelon stock holds firm as grid investment and nuclear earnings shape outlook

Exelon's stock is supported by its regulated utility profile, with recent reports indicating steady revenue growth, expanding nuclear earnings, and a significant capital plan for grid and clean-energy investments. The company reported roughly $22.1 billion in revenue for 2024, an improvement over 2023, largely …

(EXEL) Movement as an Input in Quant Signal Sets

This article analyzes Exelixis Inc. (NASDAQ: EXEL) using quantitative signals and AI models. It identifies weak near-term sentiment but potential for shifts in the mid and long-term outlook, highlighting no resistance levels above the current price. The analysis provides three distinct trading strategies (Position …

Exelon stock trades steady as regulated earnings and nuclear fleet underpin value

Exelon stock remains stable due to its regulated earnings base and significant nuclear generation capacity, as evidenced by recent financial reports. The company's consistent revenue, net income, and dividend policy, coupled with its large nuclear fleet and ongoing capital investments, provide a clear picture …

Exelon Corp. stock underperforms Friday when compared to competitors

Exelon Corp. (EXC) stock closed down 1.13% on Friday, falling to $46.26. This underperformance occurred during a general market downturn, with the S&P 500 Index and Dow Jones Industrial Average also declining. The stock is currently 8.67% below its 52-week high of $50.65.

Exelon stock trades steady as guidance and nuclear fleet underpin outlook

Exelon stock maintains a steady profile, underpinned by its regulated utility operations, substantial nuclear generation fleet, and consistent financial performance. The company reported increased revenue and adjusted earnings per share in its latest fiscal year, supporting its dividend and significant capital investment program in …